Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase NA 4Phase 3 3Phase 1/2 3

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 3Turcot syndrome 1Rectal Neoplasms 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Locally Advanced Cervical Carcinoma 1Glioblastoma 1Gallbladder Neoplasms 1Endometrial Neoplasms 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Docetaxel 33Prednisone 28enzalutamide 19Abiraterone Acetate 13pembrolizumab 11gallium 68 PSMA-11 9Leuprolide 9Radiotherapy 8Pluvicto 8Magnetic Resonance Spectroscopy 8Nivolumab 7Estramustine 7abiraterone 6Radiotherapy, Intensity-Modulated 6Goserelin 6Carboplatin 6Biopsy 6olaparib 5cemiplimab 5bicalutamide 5Specimen Handling 5Paclitaxel 5Cyclophosphamide 5temsirolimus 4orteronel 4darolutamide 4cabazitaxel 4acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 4Sirolimus 4Radiosurgery 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × Prostatic Neoplasms × Radiation Dose Hypofractionation × Clear all
NCT01505075 2020-11-24

pHART8

Sunnybrook Health Sciences Centre

Phase 1/2 Unknown
30 enrolled
Genitourinary

Prostatic Neoplasms

NCT01146340 2019-10-04

PHART6

Sunnybrook Health Sciences Centre

Phase 1/2 Completed
30 enrolled
Genitourinary

Prostatic Neoplasms

NCT00129025 2011-10-10

Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer

AHS Cancer Control Alberta

Phase 1/2 Completed
35 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡